Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
- 1 January 1979
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 32 (6) , 654-658
- https://doi.org/10.7164/antibiotics.32.654
Abstract
Isocoformycin is a structural isomer of coformycin which is a potent inhibitor of adenosine deaminase. Isocoformycin showed a weaker inhibition of this enzyme than coformycin; the binding of coformycin to enzyme was irreversible, but isocoformycin inhibition was competitive with substrate. The Ki value of isocoformycin was 4.5 .apprx. 10 .times. 10-8 M. Following i.p. injection of isocoformycin in mice, adenosine deaminase activity of homogenates of several organs was determined and the following ED50 values (50% inhibition doses) were observed: 29 mg/kg for thymus, 13 mg/kg for spleen, 80 mg/kg for liver and 20 mg/kg for kidney. Adenosine deaminase inhibition in rabbit blood in vitro was tested in comparison with coformycin.This publication has 4 references indexed in Scilit:
- EFFECTS OF 2'-DEOXYCOFORMYCIN, 9-BETA-D-ARABINOFURANOSYLADENINE 5'-PHOSPHATE, AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE TRIPLE COMBINATION THERAPY ON INTRACEREBRAL LEUKEMIA 12101977
- Enhancement of the Biological Activity of Adenosine Analogs by the Adenosine Deaminase Inhibitor 2’-DeoxycoformycinPharmacology, 1977
- ENHANCEMENT OF 9-BETA-D-ARABINOFURANOSYLADENINE CYTOTOXICITY TO MOUSE LEUKEMIA-L1210 INVITRO BY 2'-DEOXYCOFORMYCIN1976
- ENHANCEMENT OF ANTITUMOR ACTIVITY OF ARABINOFURANOSYLADENINE BY 2'-DEOXYCOFORMYCIN1976